International Organization of Physical Therapy in Mental Health consensus on physical activity within multidisciplinary rehabilitation programmes for minimising cardio-metabolic risk in patients with schizophrenia

Disability and Rehabilitation

Volumn 34, Issue 1, 2012, Pages 1-12

  Vancampfort, Davy ^a   De Hert, Marc ^a   Skjerven, Liv Helvik ^b   Gyllensten, Amanda Lundvik ^c   Parker, Anne ^d   Mulders, Nathalie ^e   Nyboe, Lene ^f   Spencer, Felicity ^g   Probst, Michel ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b BERGEN UNIVERSITY COLLEGE   (Norway)

^c LUND UNIVERSITY   (Sweden)

^d ROYAL EDINBURGH HOSPITAL   (United Kingdom)

^e Dutch Society of Psychosomatic Physical Therapy   (Netherlands)

^f AARHUS UNIVERSITY HOSPITAL   (Denmark)

^g SYDNEY CHILDREN'S HOSPITAL   (Australia)

Author keywords

Guidelines; Physical activity; Physiotherapy; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

CARDIOVASCULAR DISEASE; CONSENSUS; DISABILITY; HEALTH CARE DELIVERY; HEALTH PROMOTION; HUMAN; LIFESTYLE; METHODOLOGY; MOTOR ACTIVITY; ORGANIZATION; REVIEW; RISK FACTOR; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; CARDIOVASCULAR DISEASES; CONSENSUS; DISABILITY EVALUATION; HEALTH PROMOTION; HEALTH SERVICES ACCESSIBILITY; HUMANS; LIFE STYLE; MOTOR ACTIVITY; ORGANIZATIONS; RISK FACTORS; SCHIZOPHRENIA;

EID: 81855196041     PISSN: 09638288     EISSN: 14645165     Source Type: Journal    
DOI: 10.3109/09638288.2011.587090     Document Type: Review

References (68)

1. Rössler W, Salize HJ, van Os J, Riecher-Rössler A. Size of burden of schizophrenia and psychotic disorders. Eur Neuropsychopharmacol 2005;15:399-409. (Pubitemid 40943544)
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4 ed. Washington DC: American Psychiatric Association; 2000.
3. McGrath J, Saha S, Chant D, Welham J. Schizophrenia: A concise overview of incidence, prevalence, and mortality. Epidemiol Rev 2008;30:67-76.
4. World Health Organisation. The global burden of disease: 2004 update. Geneva: World Health Organisation; 2008.
5. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: Is the differential mortality gap worsening over time? Arch Gen Psychiatry 2007;64:1123-1131. (Pubitemid 47529346)
6. Leucht S, Burkard T, Henderson J, Maj M, Sartorius N. Physical illness and schizophrenia: A review of the literature. Acta Psychiatr Scand 2007;116:317-333. (Pubitemid 47537428)
7. DE Hert M, Schreurs V, Vancampfort D, VAN Winkel R. Metabolic syndrome in people with schizophrenia: A review. World Psychiatry 2009;8:15-22.
8. Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. Am Heart J 2005;150:1115-1121. (Pubitemid 41773510)
9. Bobes J, Arango C, Garcia-Garcia M, Rejas J. Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: An analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort. Schizophr Res 2010;119:101-109.
10. Vancampfort D, Knapen J, Probst M, van Winkel R, Deckx S, Maurissen K, Peuskens J, De Hert M. Considering a frame of reference for physical activity research related to the cardiometabolic risk profile in schizophrenia. Psychiatry Res 2010;177:271-279.
11. Mulder H, Cohen D, Scheffer H, Gispen-de Wied C, Arends J, Wilmink FW, Franke B, Egberts AC. HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia: A replication study. J Clin Psychopharmacol 2009;29:16-20.
12. Laursen TM, Munk-Olsen T, Nordentoft M, Mortensen PB. Increased mortality among patients admitted with major psychiatric disorders: A register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 2007;68:899-907. (Pubitemid 47015490)
13. Scheen AJ, De Hert MA. Abnormal glucose metabolism in patients treated with antipsychotics. Diabetes Metab 2007;33:169-175. (Pubitemid 46876639)
14. De Hert M, Schreurs V, Sweers K, Van Eyck D, Hanssens L, Sinko S, Wampers M,et al. Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in firstepisode patients with schizophrenia: A retrospective chart review. Schizophr Res 2008;101:295-303.
15. Allison DB, Newcomer JW, Dunn AL, Blumenthal JA, Fabricatore AN, Daumit GL, Cope MB,et al. Obesity among those with mental disorders: A National Institute of Mental Health meeting report. Am J Prev Med 2009;36:341-350.
16. Kilbourne AM, Morden NE, Austin K, Ilgen M, McCarthy JF, Dalack G, Blow FC. Excess heart-disease-related mortality in a national study of patients with mental disorders: Identifying modifiable risk factors. Gen Hosp Psychiatry 2009;31:555-563.
17. Roick C, Fritz-Wieacker A, Matschinger H, Heider D, Schindler J, Riedel-Heller S, Angermeyer MC. Health habits of patients with schizophrenia. Soc Psychiatry Psychiatr Epidemiol 2007; 42:268-276. (Pubitemid 46455733)
18. Lindamer LA, McKibbin C, Norman GJ, Jordan L, Harrison K, Abeyesinhe S, Patrick K. Assessment of physical activity in middleaged and older adults with schizophrenia. Schizophr Res 2008;104: 294-301.
19. Crone D, Heaney L, Herbert R, Wilson J, Johnston L, Macpherson R. A comparison of lifestyle behaviour and health perceptions of people with severe mental illness and the general population. J Ment Health Prom 2005;3:19-25.
20. Fleischhacker WW, Cetkovich-Bakmas M, De Hert M, Hennekens CH, Lambert M, Leucht S, Maj M,et al. Comorbid somatic illnesses in patients with severe mental disorders: Clinical, policy, and research challenges. J Clin Psychiatry 2008;69:514-519. (Pubitemid 351792324)
21. Fagiolini A, Goracci A. The effects of undertreated chronic medical illnesses in patients with severe mental disorders. J Clin Psychiatry 2009;70 Suppl 3:22-29.
22. Verhagen E, Engbers L. The physical therapist's role in physical activity promotion. Br J Sports Med 2009;43:99-101.
23. Institute of Medicine. Guidelines for clinical practice: From development to use. Washington DC: National Academy Press; 1992.
24. Heiskanen T, Niskanen L, Lyytikainen R, Saarinen PI, Hintikka J. 2003. Metabolic syndrome in patients with schizophrenia. J Clin Psychiatry 2003;64:575-579. (Pubitemid 36618288)
25. Vancampfort D, Knapen J, De Hert M, van Winkel R, Deckx S, Maurissen M, Peuskens J, Simons J, Probst M. Physical activity interventions for people with schizophrenia: A critical review. Phys Ther Rev 2009;14:388-398.
26. Hart C. Doing a literature search. A comprehensive guide for the social sciences. London: Sage Publications; 2001.
27. van Tulder MW, Assendelft WJ, Koes BW, Bouter LM. Method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group for Spinal Disorders. Spine 1997;22:2323-2330. (Pubitemid 28069099)
28. Archie S, Wilson JH, Osborne S, Hobbs H, McNiven J. Pilot study: Access to fitness facility and exercise levels in olanzapine-treated patients. Can J Psychiatry 2003;48:628-632. (Pubitemid 37429468)
29. Fogarty M, Happell B, Pinikahana J. The benefits of an exercise program for people with schizophrenia: A pilot study. Psychiatr Rehabil J 2004;28:173-176. (Pubitemid 39557813)
30. Beebe LH, Tian L, Morris N, Goodwin A, Allen SS, Kuldau J. Effects of exercise on mental and physical health parameters of persons with schizophrenia. Issues Ment Health Nurs 2005;26:661-676. (Pubitemid 41022038)
31. Marzolini S, Jensen B, Melville P. Feasibility and effects of a groupbased resistance and aerobic exercise program for individuals with severe schizophrenia: A multidisciplinary approach. MENPA 2009;2:29-36.
32. Carter-Morris P, Faulkner G. A football project for service users: The role of football in reducing social exclusion. J Ment Health Prom 2003;2:24-30.
33. McDevitt J, Snyder M, Miller A, Wilbur J. Perceptions of barriers and benefits to physical activity among outpatients in psychiatric rehabilitation. J Nurs Scholarsh 2006;38:50-55. (Pubitemid 43448646)
34. Archie SM, Goldberg JO, Akhtar-Danesh N, Landeen J, McColl L, McNiven J. Psychotic disorders, eating habits, and physical activity: Who is ready for lifestyle changes? Psychiatr Serv 2007;58: 233-239. (Pubitemid 46340468)
35. Duraiswamy G, Thirthalli J, Nagendra HR, Gangadhar BN. Yoga therapy as an add-on treatment in the management of patients with schizophrenia-a randomized controlled trial. Acta Psychiatr Scand 2007;116:226-232. (Pubitemid 47106661)
36. Faulkner G, Taylor A, Munro S, Selby P, Gee C. The acceptability of physical activity programming within a smoking cessation service for individuals with severe mental illness. Patient Educ Couns 2007;66:123-126. (Pubitemid 46366615)
37. Ussher M, Stanbury L, Cheeseman V, Faulkner G. Physical activity preferences and perceived barriers to activity among persons with severe mental illness in the United Kingdom. Psychiatr Serv 2007;58:405-408. (Pubitemid 46480060)
38. Johnstone R, Nicol K, Donaghy M, Lawrie S. Barriers to uptake of physical activity in community-based patients with schizophrenia. J Ment Health 2009;18:523-532.
39. Vancampfort D, De Hert M, Maurissen K, Sweers K, Knapen J, Raepsaet J, Probst M. Physical activity participation, cardiorespiratory fitness and self-esteem in patients with schizophrenia with high and low physical self perception. IJTR 2011;8:222-229
40. Trost SG, Owen N, Bauman AE, Sallis JF, Brown W. Correlates of adults' participation in Physical activity: Review and update Med Sci Sports Exerc 2002;34:1996-2001.
41. American Diabetes Association. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diab Care 2004;27:596-601.
42. Dinan TG. Schizophrenia and diabetes 2003: An expert consensus meeting. Br J Psychiatry 2004;S47:53-54.
43. Lambert TJ, Chapman LH; Consensus Working Group. Diabetes, psychotic disorders and antipsychotic therapy: A consensus statement. Med J Aust 2004;181:544-548. (Pubitemid 39545630)
44. Marder SR, Essock SM, Miller AL, Buchanan RW, Casey DE, Davis JM, Kane JM,et al. Physical health monitoring of patients with schizophrenia. Am J Psychiatry 2004;161:1334-1349. (Pubitemid 38989085)
45. Melkersson KI, Dahl ML, Hulting AL. Guidelines for prevention and treatment of adverse effects of antipsychotic drugs on glucose-insulin homeostasis and lipid metabolism. Psychopharmacology (Berl) 2004;175:1-6. (Pubitemid 39215524)
46. Poulin MJ, Cortese L, Williams R, Wine N, McIntyre RS. Atypical antipsychotics in psychiatric practice: Practical implications for clinical monitoring. Can J Psychiatry 2005;50:555-562. (Pubitemid 43161788)
47. Usher K, Foster K, Park T. The metabolic syndrome and schizophrenia: The latest evidence and nursing guidelines for management. J Psychiatr Ment Health Nurs 2006;13:730-734. (Pubitemid 44706032)
48. Barnett AH, Mackin P, Chaudhry I, Farooqi A, Gadsby R, Heald A, Hill J,et al. Minimising metabolic and cardiovascular risk in schizophrenia: Diabetes, obesity and dyslipidaemia. J Psychopharmacol (Oxford) 2007;21:357-373. (Pubitemid 47077296)
49. De Nayer A, De Hert M, Scheen A, Van Gaal L, Peuskens J. [Conference report: Belgian consensus on metabolic problems associated with atypical antipsychotics]. Encephale 2007;33:197-202. (Pubitemid 46787708)
50. Sáiz Ruiz J, Bobes García J, Vallejo Ruiloba J, Giner Ubago J, García-Portilla González MP; Grupo de Trabajo sobre la Salud Física del Paciente con Esquizofrenia. [Consensus on physical health of patients with schizophrenia from the Spanish Societies of Psychiatry and Biological Psychiatry]. Actas Esp Psiquiatr 2008;36:251-264.
51. De Hert M, Dekker JM, Wood D, Kahl KG, Holt RI, Möller HJ. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry 2009;24:412-424.
52. Gothefors D, Adolfsson R, Attvall S, Erlinge D, Jarbin H, Lindström K, von Hausswolff-Juhlin YL,et al.; Swedish Psychiatric Association. Swedish clinical guidelines-prevention and management of metabolic risk in patients with severe psychiatric disorders. Nord J Psychiatry 2010;64:294-302.
53. European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice. Fourth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice European guidelines on cardiovascular disease prevention in clinical practice: Executive summary. Eur J Cardiovasc Prev Rehabil 2007;14:1-40.
54. U.S. Department of Health and Human Services. Physical activity guidelines for Americans, Washington DC: U.S. Department of Health and Human Services; 2008.
55. De Hert M, Vancampfort D, Correll CU, Mercken V, Peuskens J, Sweers K, van Winkel R, Mitchell AJ. Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation. Br J Psychiatry 2011;199:99-105.
56. De Hert M, Cohen D, Bobes J, Cetkovich-Bakmas M, Leucht S, Ndetei DM, Newcomer JW,et al. Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry 2011;10:138-151.
57. Eden KB, Orleans CT, Mulrow CD, Pender NJ, Teutsch SM. Does counseling by clinicians improve physical activity? A summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137:208-215. (Pubitemid 34827518)
58. Ross R, Blair SN, Godwin M, Hotz S, Katzmarzyk PT, Lam M, Lévesque L, Macdonald S. Prevention and Reduction of Obesity through Active Living (PROACTIVE): Rationale, design and methods. Br J Sports Med 2009;43:57-63.
59. Straker D, Correll CU, Kramer-Ginsberg E, Abdulhamid N, Koshy F, Rubens E, Saint-Vil R,et al. Cost-effective screening for the metabolic syndrome in patients treated with second-generation antipsychotic medications. Am J Psychiatry 2005;162: 1217-1221. (Pubitemid 40770711)
60. Priebe S, Röhricht F. Specific body image pathology in acute schizophrenia. Psychiatry Res 2001;101:289-301. (Pubitemid 32324234)
61. Probst M, Knapen J, Poot G, Vancampfort D. Psychomotor therapy and psychiatry: What's in a name? Open Compl Med J 2010; 2: 105-113.
62. Medalia A, Brekke J. In search of a theoretical structure for understanding motivation in schizophrenia. Schizophr Bull 2010;36:912-918.
63. Sørensen M. Motivation for physical activity of psychiatric patients when physical activity was offered as part of treatment. Scand J Med Sci Sports 2006;16:391-398. (Pubitemid 44715456)
64. Putzhammer A, Heindl B, Broll K, Pfeiff L, Perfahl M, Hajak G. Spatial and temporal parameters of gait disturbances in schizophrenic patients. Schizophr Res 2004;69:159-166. (Pubitemid 38721415)
65. Pedersen BK, Saltin B. Evidence for prescribing exercise as therapy in chronic disease. Scand J Med Sci Sports 2006;16 Suppl 1:3-63. (Pubitemid 43433766)
66. Rüsch N, Corrigan PW. Motivational interviewing to improve insight and treatment adherence in schizophrenia. Psychiatr Rehabil J 2002;26:23-32.
67. Richardson CR, Faulkner G, McDevitt J, Skrinar GS, Hutchinson DS, Piette JD. Integrating physical activity into mental health services for persons with serious mental illness. Psychiatr Serv 2005;56:324-331. (Pubitemid 40333566)
68. Torres-Carbajo A, Olivares JM, Merino H, Vazquez H, Diaz A, Cruz, E. Efficacy and effectiveness of an exercise programme as community support for schizophrenic patients. Am J Rec Ther 2005;4:41-47. Implications for Rehabilitation.